Drug maker Elder Pharmaceuticals today said its consolidated net profit rose by 2.34% to Rs 15.73 crore for the quarter ended December 31, 2010, over the same period previous fiscal.
The company had a net profit of Rs 15.37 crore in the corresponding period of last fiscal, Elder Pharmaceuticals said in a filing to the Bombay Stock Exchange (BSE).
Total income of the company rose to Rs 261.73 crore for the quarter ended December 31, 2010, compared to Rs 180.17 crore in the same period of previous fiscal.
"Growth within the country has been phenomenal. All our brands, across various segments have shown growth during the period," Elder Pharmaceuticals Director Alok Saxena said.
Shares of Elder Pharma were today trading at Rs 365.05 on BSE in the late afternoon trade, down 1.02% from its previous close.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app